US President Donald Trump Presented here on Friday his plan to lower drug prices in the US, a strategy that seeks, among other things, to force other countries to increase their drug prices to bring down costs at home.
"It's time to end the global freeloading once and for all. I have directed US Trade Representative Bob Lighthizer to make fixing this injustice a top priority with every trading partner," Trump said during a speech at the White House Rose Garden, Efe reported.
"We have great power over the trading partners; you're seeing that already. America will not be cheated any longer, and especially will not be cheated by foreign countries," the President added.
Trump argued that other countries take advantage of the US pharmaceutical industry and its investments in research and development, claiming that bringing downs costs at home would require increasing prices in foreign countries.
All of the world's 10 largest pharmaceutical companies operate globally.
Five of them are based in the United States, two in Switzerland, and one each in France, the United Kingdom and Germany.
"When foreign governments extort unreasonably low prices from US drug makers, Americans have to pay more to subsidize the enormous cost of research and development," Trump said.
"In some cases, medicine that costs a few dollars in a foreign country costs hundreds of dollars in America for the same pill, with the same ingredients, in the same package, made in the same plant," the real estate mogul said.
Trump considered that this situation was "unacceptable," claiming that "it's not going to happen any longer."
According to figures from the Organization for Economic Cooperation and Development, US consumers spent $1,162 per person on pharmaceuticals in 2015, compared to $756 in Canada and $497 in the UK, where the government has established measures to control drug prices.
--IANS
ahm/
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
